High levels of serum prostate-specific antigen due to PSA producing follicular non-Hodgkin's lymphoma

Eur J Haematol. 2007 Aug;79(2):155-8. doi: 10.1111/j.1600-0609.2007.00883.x.

Abstract

Objective: Both carcinoma of the prostate and non-Hodgkin's lymphoma are common in elderly patients. Measurement of serum prostate-specific antigen (PSA) is a frequently used tool to diagnose and monitor prostate carcinoma and is generally specific for diseases of the prostate.

Case: We describe a 68-yr-old patient with voiding difficulties and high PSA levels, but without inflammatory or malignant changes upon multiple transrectal ultrasound guided prostate biopsies. Digital rectal examination was normal. Laboratory showed a strongly elevated PSA level (62 microg/L, Immulight 2000); DPC, USA). A CT-scan showed a retroperitoneal process with mass in the right pelvis and infiltration of the bladder wall, suggestive for metastatic prostate carcinoma. Surgical excision of an axillary lymph node set the diagnosis at a stage IV follicular lymphoma, Berard grade I to II in which the majority of neoplastic cells expressed PSA. After lymphoma-specific treatment, there was a positron emission tomography (PET) confirmed complete remission with normal PSA levels (6 microg/L), which still persists.

Conclusion: Although rare, high PSA levels can be due to the presence of non-Hodgkin's lymphoma. Such a diagnosis should be considered when patients present with lymphadenopathy other than regional prostatic lymphadenopathy.

Publication types

  • Case Reports

MeSH terms

  • Aged
  • Antigens, CD20 / metabolism
  • Humans
  • Lymphoma, Follicular / blood*
  • Lymphoma, Follicular / pathology*
  • Male
  • Prostate-Specific Antigen / blood*

Substances

  • Antigens, CD20
  • Prostate-Specific Antigen